X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs IPCA LABS - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS IPCA LABS J.B.CHEMICALS/
IPCA LABS
 
P/E (TTM) x 13.5 36.4 37.2% View Chart
P/BV x 2.1 3.5 61.9% View Chart
Dividend Yield % 0.2 0.1 121.8%  

Financials

 J.B.CHEMICALS   IPCA LABS
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
IPCA LABS
Mar-17
J.B.CHEMICALS/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs318643 49.5%   
Low Rs200503 39.7%   
Sales per share (Unadj.) Rs148.0254.4 58.2%  
Earnings per share (Unadj.) Rs19.116.1 118.8%  
Cash flow per share (Unadj.) Rs23.929.8 80.4%  
Dividends per share (Unadj.) Rs0.501.00 50.0%  
Dividend yield (eoy) %0.20.2 110.7%  
Book value per share (Unadj.) Rs128.9194.6 66.3%  
Shares outstanding (eoy) m84.82126.20 67.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.3 77.7%   
Avg P/E ratio x13.635.7 38.0%  
P/CF ratio (eoy) x10.819.2 56.2%  
Price / Book Value ratio x2.02.9 68.2%  
Dividend payout %2.66.2 42.1%   
Avg Mkt Cap Rs m21,95172,300 30.4%   
No. of employees `0002.713.3 20.6%   
Total wages/salary Rs m1,8416,960 26.5%   
Avg. sales/employee Rs Th4,590.92,413.5 190.2%   
Avg. wages/employee Rs Th673.4523.2 128.7%   
Avg. net profit/employee Rs Th592.1152.4 388.4%   
INCOME DATA
Net Sales Rs m12,55132,106 39.1%  
Other income Rs m542226 240.0%   
Total revenues Rs m13,09332,332 40.5%   
Gross profit Rs m2,0554,448 46.2%  
Depreciation Rs m4121,730 23.8%   
Interest Rs m96241 39.7%   
Profit before tax Rs m2,0882,703 77.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469675 69.5%   
Profit after tax Rs m1,6192,028 79.8%  
Gross profit margin %16.413.9 118.2%  
Effective tax rate %22.525.0 89.9%   
Net profit margin %12.96.3 204.2%  
BALANCE SHEET DATA
Current assets Rs m7,77817,340 44.9%   
Current liabilities Rs m4,3589,559 45.6%   
Net working cap to sales %27.224.2 112.4%  
Current ratio x1.81.8 98.4%  
Inventory Days Days55100 54.5%  
Debtors Days Days8057 140.7%  
Net fixed assets Rs m5,71320,779 27.5%   
Share capital Rs m170252 67.2%   
"Free" reserves Rs m10,54724,499 43.0%   
Net worth Rs m10,93724,553 44.5%   
Long term debt Rs m03,517 0.0%   
Total assets Rs m15,57439,595 39.3%  
Interest coverage x22.812.2 186.7%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.8 99.4%   
Return on assets %11.05.7 192.1%  
Return on equity %14.88.3 179.2%  
Return on capital %20.010.5 190.3%  
Exports to sales %48.748.6 100.2%   
Imports to sales %7.114.2 49.7%   
Exports (fob) Rs m6,11515,617 39.2%   
Imports (cif) Rs m8894,571 19.4%   
Fx inflow Rs m6,16915,617 39.5%   
Fx outflow Rs m1,2855,828 22.1%   
Net fx Rs m4,8849,790 49.9%   
CASH FLOW
From Operations Rs m1,3972,764 50.5%  
From Investments Rs m-320-1,432 22.4%  
From Financial Activity Rs m-1,196-1,591 75.1%  
Net Cashflow Rs m-102-259 39.5%  

Share Holding

Indian Promoters % 55.4 45.9 120.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 11.4 29.7%  
FIIs % 3.9 25.3 15.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.4 212.6%  
Shareholders   30,437 36,892 82.5%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  TTK HEALTHCARE  SHASUN PHARMA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Oil Prices; RBI Minutes and Top Stocks in Action Today(Pre-Open)

Indian share markets surged on Wednesday, snapping a two-day losing streak led by gains Reliance Industries and bank stocks.

Related Views on News

IPCA LABS Announces Quarterly Results (4QFY18); Net Profit Up 15.6%

May 30, 2018 | Updated on May 30, 2018

For the quarter ended March 2018, IPCA LABS has posted a net profit of Rs 513 m (up 15.6% YoY). Sales on the other hand came in at Rs 8 bn (up 17.6% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 20, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - PIRAMAL ENTERPRISES COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS